**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 3524-62-7 |Benzoin methyl ether | 93.0 | 222-538-7 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed. May cause digestive tract disturbances.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Avoid ingestion and
inhalation.
Storage:
Keep container closed when not in use. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels.
Exposure Limits
CAS# 3524-62-7:
Personal Protective Equipment
Eyes:
Wear safety glasses and chemical goggles if splashing
is possible.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: Not available.
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 49 deg C
Autoignition Temperature: Not available.
Flash Point: > 110 deg C (> 230.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H14O2
Molecular Weight: 226.27
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents - strong acids.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 3524-62-7: AM9350000
LD50/LC50:
CAS# 3524-62-7: Oral, mouse: LD50 = 300 mg/kg; Oral, mouse: LD50 =
2750 mg/kg; Oral, rat: LD50 = 7560 mg/kg.
Carcinogenicity:
Benzoin methyl ether -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
S 22 Do not breathe dust.
WGK (Water Danger/Protection)
CAS# 3524-62-7: No information available.
Canada
CAS# 3524-62-7 is listed on Canada's NDSL List.
CAS# 3524-62-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3524-62-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/24/1997 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-Hydroxy-4-Methoxycinnamic Acid, 97%, Predominantly Trans
| 537-73-5 |
|
4'-Methoxypropiophenone, 99%
| 121-97-1 |
|
L-Thyroxine, 99%
| 51-48-9 |
|
Cholesteryl Propionate
| 633-31-8 |
|
Benzoin methyl ether, 93% (hplc)
| 3524-62-7 |
|
Cadmium oxide, brown, 99%
| 1306-19-0 |
|
4-Chlorobutyronitrile, 98+%
| 628-20-6 |
|
2-Chloro-6-Methyl-3-Pyridinecarboxylic Acid, 99+%
| 30529-70-5 |
|
bis(2-Ethylhexyl) sebacate, 97+% (gc)
| 122-62-3 |
|
Tween 60
| 9005-67-8 |
|
3,3'-Carbonylbis(7-Diethylaminocoumarin), 99% (UV-Vis)
| 63226-13-1 |
|
1-Naphthoic acid, 98%
| 86-55-5 |
|
4-Ethylanisole, 99%
| 1515-95-3 |
|
3-(Diethylamino)propionitrile 98%
| 5351-04-2 |
|
4-Hydroxydiphenylmethane, 96%
| 101-53-1 |
|
Heptanoic Acid
| 111-14-8 |
|
Diisobutylaluminum hydride, 20 wt.% solution in toluene
| 108-88-3 |
|
trans-Methyl crotonate, 98%
| 623-43-8 |
|
(1R)-Cis-Chrysanthemylamine Hydrochloride 95%
| 0-01-1 |
|
1-Hydroxy-6-Methylsulphonylindole, 95+%
| |
|
Direct black 22
| 6473-13-8 |
|
N-Heptyl-Triphenylphosphonium Bromide, 99%
| 13423-48-8 |
|
Hexamethyldisiloxane, 98+%
| 107-46-0 |
|
2-Nonanol, 99%
| 628-99-9 |
|
(S)-(+)-Phenylsuccinic Acid, 99+%
| 4036-30-0 |
|
1,4-Diiodobutane, 98%
| 628-21-7 |
|
Methyl 1-Methoxybicyclo(2.2.2)oct-5-ene-2- Carboxylate, 98%
| 5259-50-7 |
|
Trichloroacetyl isocyanate
| 3019-71-4 |
|
Methyl sulfone, 98%
| 67-71-0 |
|
Coralyne Chloride, Hydrate, 98+%
| 38989-38-7 |
|
1,2,3,4-Tetraphenyl-1,3-cyclopentadiene, 98%
| 15570-45-3 |
|
4-Bromofluorobenzene, 99%
| 460-00-4 |
|
Vinyltriacetoxysilane, monomer, 90%
| 4130-08-9 |
|
1,1-Dimethoxyethane, 95% (gc)
| 534-15-6 |
|
Azure B Eosinate
| 62298-42-4 |
|
O-Methylisourea Hemisulfate, 94%
| 52328-05-9 |
|
5-Bromo-DL-Tryptophan, 99%
| 6548-09-0 |
|
n-Methyl-2-nitroaniline, 98%
| 612-25-9 |
|
1-(3-Chlorophenyl)-4-(3-Chloropropyl)piperazine Hydrochloride,
| 39577-43-0 |
|
3-Benzoylpropionic Acid, 98%
| 2051-95-8 |
|
Mercury Cyclohexanebutyrate
| 62638-02-2 |
|
4-Chloro-1-[4-(1,1-Dimethylethyl)Phenyl]-1-Butanone, 98+% (GC)
| 43076-61-5 |
|
Butyl Formate, 98% (GC)
| 592-84-7 |
|
5-Hydroxy-p-naphthoquinone, 97%
| 481-39-0 |
|
11alpha-Hydroxy-17alpha-methyltestosterone
| 1043-10-3 |
|
MBD
| 33984-50-8 |
|
Mucochloric acid, 99%(titr.,dry substance)
| 87-56-9 |
|
N-Alpha-Acetyl-L-Lysine, 99+%
| 1946-82-3 |
|
Vanadyl phthalocyanine (pract)
| 13930-88-6 |
|
(2R,3S)-1-Carboxy-4-Ethyl-2,3-Dihydroxy-Cyclohexa-4,6-Diene, Sodium
| 0-01-1 |
|
|